Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Apr 14, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-04-11$0.80/sh+20,000$16,000→ 1,098,460 total
Footnotes (1)
- [F1]Reflects open market purchases of the Issuer's securities.